Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor

MLA

Turkman, Nashaat, et al. “Synthesis and Preliminary Evaluation of [18F]-Labeled 2-Oxoquinoline Derivatives for PET Imaging of Cannabinoid CB2 Receptor.” Nuclear Medicine & Biology, vol. 39, no. 4, May 2012, pp. 593–600. EBSCOhost, https://doi.org/10.1016/j.nucmedbio.2011.10.019.

APA

Turkman, N., Shavrin, A., Paolillo, V., Yeh, H. H., Flores, L., Soghomonian, S., Rabinovich, B., Volgin, A., Gelovani, J., & Alauddin, M. (2012). Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor. Nuclear Medicine & Biology, 39(4), 593–600. https://doi.org/10.1016/j.nucmedbio.2011.10.019

Chicago

Turkman, Nashaat, Aleksander Shavrin, Vincenzo Paolillo, Hsin Hsien Yeh, Leo Flores, Suren Soghomonian, Brian Rabinovich, Andrei Volgin, Juri Gelovani, and Mian Alauddin. 2012. “Synthesis and Preliminary Evaluation of [18F]-Labeled 2-Oxoquinoline Derivatives for PET Imaging of Cannabinoid CB2 Receptor.” Nuclear Medicine & Biology 39 (4): 593–600. doi:10.1016/j.nucmedbio.2011.10.019.